1 Khadilkar SV, Sahni AO, Patil SG. Myasthenia gravis. Journal of the Association of Physicians of India. 2018;52:897.
2 Zhang GX, Navikas V, Link H. Cytokines and the pathogenesis of myasthenia gravis. MUSCLE NERVE. 2015;20:543-51.
3 Lixiang C, Hughes RA, Baines AJ, John C, Narla M, Xiuli A. Protein 4.1R regulates cell adhesion, spreading, migration and motility of mouse keratinocytes by modulating surface expression of beta1 integrin. J CELL SCI. 2011;doi:10.1242/jcs.078170.
4 Baines AJ, Lu H, Bennett PM. The Protein 4.1 family: Hub proteins in animals for organizing membrane proteins. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2014 2014-01-01;1838:605-19.
5 Narla J, Mohandas N. Red cell membrane disorders. INT J LAB HEMATOL. 2017 2017-05-01;39 Suppl 1:47-52.
6 Fan D, Zhang X, Guo Y et al.. Protein 4.1R negatively regulates CD8~+ T cells activation by modulating the phosphorylation of LAT. In. Proceedings of the Exchange report on the Sub-venue of the 13th National Congress on Immunology , 2018.
7 Zheng XY, Qi YM, Gao YF et al.. [Expression and significance of membrane skeleton protein 4.1 family in non-small cell lung cancer]. CHIN J CANCER. 2009;doi:10.5732/cjc.008.10851.
8 Delhommeau F, Venezia ND, Morinière M et al.. Protein 4.1R expression in normal and dystrophic skeletal muscle. C R Biol. 2005; doi:10.1016/j.crvi.2004.11.003.
9 Witold D, Micha G, Sikorski AF. Protein 4.1, a component of the erythrocyte membrane skeleton and its related homologue proteins forming the protein 4.1/FERM superfamily, 2006;doi:10.5603/4555.
10 Emilie G, Xinhua G, Narla M, Xiuli A. Phosphorylation-dependent perturbations of the 4.1R-associated multiprotein complex of the erythrocyte membrane. BIOCHEMISTRY-US. 2011;doi:10.1021/bi200154g.
11 Sumie M, Yuichi T, Narla M. Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation. J BIOL CHEM. 2005;doi:10.1074/jbc.M410650200.
12 Stagg M, Carter E, Sohrabi NU et al.. Cytoskeletal protein 4.1R affects repolarization and regulates calcium handling in the heart. CIRC RES. 2008;doi: 10.1161/CIRCRESAHA.108.176461.
13 Nunomura W, Takakuwa Y. Regulation of protein 4.1R interactions with membrane proteins by Ca2+ and calmodulin. Frontiers in Bioscience A Journal & Virtual Library. 2006;doi:10.2741/1901.
14 Robb VA, Wen L, Philippe G, Arie P, Narla M, Gutmann DH. Identification of a third Protein 4.1 tumor suppressor, Protein 4.1R, in meningioma pathogenesis. NEUROBIOL DIS. 2003;doi:10.1016/s0969-9961(03)00071-8.
15 Qiaozhen K, Yu Y, Xinhong P et al.. Cytoskeletal protein 4.1R negatively regulates T-cell activation by inhibiting the phosphorylation of LAT. BLOOD. 2009;doi:10.1182/blood-2008-10-182329.
16 Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B. Diagnostic and clinical classification of autoimmune myasthenia gravis. J AUTOIMMUN. 2014;doi:10.1016/j.jaut.2014.01.003.
17 Gao F, Zhao Y, Cui X et al.. Expression of Protein 4.1R as the distinguishing feature of hyperplastic thymus tissue with myasthenia gravis. Life Science Journal. 2014;11:135-9.
18 Phillips WD, Vincent A. Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms. F1000research. 2016;doi:10.12688/f1000research.8206.1.
19 Takeshi K, Ayako T, Akito T, Tomoyuki N. The linoleic acid derivative DCP-LA increases membrane surface localization of the α7 ACh receptor in a protein 4.1N-dependent manner. BIOCHEM J. 2013;doi:10.1042/bj20121348.
20 Dorion S, Sundar E, Panzica P, Cunningham K, Simon R. Characterization of cytoskeletal protein 4.1R interaction with NHE1 (Na(+)/H(+) exchanger isoform 1). BIOCHEM J. 2012;doi:10.1042/BJ20120535.
21 Pinder JC, Taylor-Harris PM, Bennett PM et al.. Isoforms of protein 4.1 are differentially distributed in heart muscle cells: relation of 4.1R and 4.1G to components of the Ca2+ homeostasis system. EXP CELL RES. 2012;doi:10.1016/j.yexcr.2012.03.003.
22 Prinston JE, Emlaw JR, Dextraze MF et al.. Ancestral Reconstruction Approach to Acetylcholine Receptor Structure and Function. STRUCTURE.2017; doi:10.1016/j.str.2017.06.005.